发明名称 |
NON-PEGYLATED LIPOSOMAL DOXORUBICIN TRIPLE COMBINATION THERAPY |
摘要 |
The present invention relates to a method for treating metastatic breast cancer in an individual comprising administering to an individual in need thereof a dosing regimen which comprises administering to the individual nonpegylated liposomal doxorubicin, a taxane and a HER2/neu receptor antagonist, wherein the individual previously has been administered an anthracycline.
|
申请公布号 |
US2011256215(A1) |
申请公布日期 |
2011.10.20 |
申请号 |
US201113172588 |
申请日期 |
2011.06.29 |
申请人 |
SOPHERION THERAPEUTICS LLC |
发明人 |
ROZENCWEIG MARCEL;GOLDFARB RONALD H.;FORENZA SALVATORE |
分类号 |
A61K9/127;A61K39/395;A61P35/04 |
主分类号 |
A61K9/127 |
代理机构 |
|
代理人 |
|
主权项 |
|
地址 |
|